Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Increased Thromboinflammation Is Associated with High Thrombotic Risk in Patients with Myeloproliferative Neoplasms: A Multicentric Study of 394 Cases By the French Intergroup of Myeloproliferative Neoplasms (FIM)

Blood (2024) 144 (Supplement 1): 3133.

https://doi.org/10.1182/blood-2024-194702

Published: 2024

Journal Articles

Interleukin 10 (IL10) and IL15 Significantly Decreased in Chronic Myeloid Leukemia Patients Presenting with Tyrosine Kinase Inhibitor (TKI) Withdrawal Syndrome (TWS). Results from the Prospective, Explorative and Multicenter « Kiwis » Study Designed for TWS. Clinicaltrial.Gov ID: NCT03996096; Study Number: 18-206

Hyacinthe A. Johnson-Ansah, Anaïs Briant, Amandine Charbonnier, Nathalie Cambier, Gandhi Laurent Damaj, Pascal Lenain, Alexandra Henry, Jean-Jacques Parienti, David Guenet, Anne-Claire GAC Besnard, Baptiste Delapierre, Franck E. Nicolini, Brigitte Le Mauff, Marc G. Berger

Blood (2023) 142 (Supplement 1): 6335.

https://doi.org/10.1182/blood-2023-177651

Published: 2023

Journal Articles

Momelotinib (MMB) Long-Term Safety: Pooled Data from Three Phase 3 Randomized-Controlled Trials (RCTs)

Blood (2022) 140 (Supplement 1): 9670–9672.

https://doi.org/10.1182/blood-2022-162543

Published: 2022

Journal Articles

Treatment with Temozolomide and Ibrutinib in Recurrent/Refractory Primary (PCNSL) and Secondary CNS Lymphoma (SCNSL)

Loïc Renaud, MD MSc, Jean-Baptiste Bossard, MD MSc, Louis Terriou, Nathalie Cambier, MD, Guillaume Chanteau, Benjamin Carpentier, MD, Sarah Barbieux, MD, Mathieu Wemeau, MD, Julia Hieulle, Eileen M Boyle, MDMSc, Franck Morschhauser, MD PhD

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-138764

Published: 2020

Journal Articles

Impact of DNMT3a Status on Post Induction NPM1 MRD Predictive Value on Survival in Elderly AML Patients Treated Intensively

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-141890

Published: 2020

Journal Articles

Chemotherapy Treatment Doesn't Beneficiate to a Group of Elderly AML Patients with Absence of Complex Karyotype and Circulating Blasts

Berengere Gruson, MD, Magalie Joris, Olivier Nibourel, Véronique Harrivel, MD, Nathalie Cambier, MD, Pauline Lionne, Bachra Choufi, Celine Rodriguez, Cecile Frimat, Isabelle Plantier, MD, Laure Stalnikiewicz, Maxime Bemba, Céline Berthon, MD PhD, Claude Preudhomme, Pierre Morel, MD, Jean-Pierre Marolleau, MD PhD

Blood (2018) 132 (Supplement 1): 2679.

https://doi.org/10.1182/blood-2018-99-116144

Published: 2018

Journal Articles

A Two-Part Study of Givinostat in Patients with Polycythemia Vera: The Maximum Tolerated Dose Selection and the Proof of Concept Final Results

Blood (2017) 130 (Supplement 1): 253.

https://doi.org/10.1182/blood.V130.Suppl_1.253.253

Published: 2017

Journal Articles

Myelofibrosis in Real Life: Findings from the French Intergroup of Myeloproliferative Neoplasms (FIM) Registry

Blood (2016) 128 (22): 3128.

https://doi.org/10.1182/blood.V128.22.3128.3128

Published: 2016

Journal Articles

A Two-Part Study of Givinostat in Patients with Polycythemia Vera: Maximum Tolerated Dose Definition and Preliminary Efficacy Results

Guido Finazzi, MD, Bruno Martino, MD, Antonio Pezzuto, Andrzej Hellmann, MD, Mary Frances McMullin, MD, Richard Noble, MD, Nikolas von Bubnoff, Prof., PhD, Nathalie Cambier, MD, Jean-Pierre Marolleau, MD PhD, Marco Ruggeri, MD, Alessandro M. Vannucchi, MD PhD, Ruben Mesa, MD FACP, Raoul Tibes, MD PhD, Paolo Bettica, MD PhD, Silvia DI Tollo, DHSC, BSc, Alessandro Rambaldi, MD

Blood (2016) 128 (22): 4261.

https://doi.org/10.1182/blood.V128.22.4261.4261

Published: 2016

Journal Articles

Procoagulant Platelet-Derived Microparticles Are Lower in Calreticulin-Than in-JAK2-Mutated Essential Thrombocythemia

Agnes Charpentier, MD, Nathalie Cambier, MD, Anne Bauters, Nathalie Trillot, MD, Matthieu Wemeau, MD, Olivier Nibourel, Veronique Tintillier, MD, Jean-Loup Demory, MD, Claude Preudhomme, PharmD, PhD, Brigitte Jude, MD PhD, Sophie Susen, MDPhD

Blood (2014) 124 (21): 110.

https://doi.org/10.1182/blood.V124.21.110.110

Published: 2014

Journal Articles

Prognostic Of IgD Myeloma In The Era Of Novel Agents

Blood (2013) 122 (21): 1880.

https://doi.org/10.1182/blood.V122.21.1880.1880

Published: 2013

Journal Articles

High Prevalence Of Aspirin-Resistance In Myeloproliferative Neoplasms

Jean-Loup Demory, MD, Judith Bruge, Nathalie Cambier, MD, Christian Rose, MD, Agnès Charpentier, MD

Blood (2013) 122 (21): 5250.

https://doi.org/10.1182/blood.V122.21.5250.5250

Published: 2013

Journal Articles

Enumeration of Circulating Platelet-Derived Microparticles Clearly Separates PV and ET From Secondary Polycythemia or Thrombocytosis

Agnés Charpentier, MD, Stéphanie Devaux, Véronique Tintillier-Colin, MD, Matthieu Wemeau, MD, Judith Bruge-Debreu, MD, Nathalie Cambier, MD, Brigitte Jude, MD, PhD, Jean-Loup Demory, MD

Blood (2011) 118 (21): 1745.

https://doi.org/10.1182/blood.V118.21.1745.1745

Published: 2011

Journal Articles

The Phenotypic Profile of Circulating Microparticles Is Different in Polycythemia Vera and Secondary Erythrocytosis

Agnès Charpentier, MD, Stéphanie Devaux, Judith Bruge-Debreu, MD, Nathalie Cambier, MD, Christian Rose, MD, PhD, Jean-Loup Demory, MD

Blood (2011) 118 (21): 5166.

https://doi.org/10.1182/blood.V118.21.5166.5166

Published: 2011

Journal Articles

Complete Hematological, Molecular and Histological Remissions without Cytoreductive Treatment Lasting After Pegylated-Interferon α-2a (peg-IFNα-2a) Therapy in Polycythemia Vera (PV): Long Term Results of a Phase 2 Trial

Pascal Turlure, MD, Nathalie Cambier, MD, Murielle Roussel, Sylvia Bellucci, MD, PhD, Jean-Marc Zini, MD, PhD, Jean-Didier Rain, MD, Philippe Rousselot, MD, PhD, William Vainchenker, MD, PhD, Lina Abdelkader, Kamel Ghomari, Jean-Luc Dutel, Yasmine Chait, Sylvie Chevret, Christine Chomienne, MD, PhD, Bruno Cassinat, PharmD, Jean-Jacques Kiladjian, MD, PhD

Blood (2011) 118 (21): 280.

https://doi.org/10.1182/blood.V118.21.280.280

Published: 2011

Journal Articles

Elevated Circulating Platelet-Derived Microparticles in Ph1 Negative Chronic Myeloproliferative Disorders.

Véronique Tintillier-Colin, Nathalie Cambier, MD, Emmanuelle Bourgeois-Petit, MD, Christian Rose, MD, Gérard Forzy, MD, Jean-Loup Demory, MD, Agnès Charpentier, MD

Blood (2009) 114 (22): 1906.

https://doi.org/10.1182/blood.V114.22.1906.1906

Published: 2009

Journal Articles

Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera

Jean-Jacques Kiladjian, Bruno Cassinat, Sylvie Chevret, Pascal Turlure, Nathalie Cambier, Murielle Roussel, Sylvia Bellucci, Bernard Grandchamp, Christine Chomienne, Pierre Fenaux

Blood (2008) 112 (8): 3065–3072.

https://doi.org/10.1182/blood-2008-03-143537

Published: 2008

Journal Articles

Treatment of AML with Azacytidine (AZA): Current Results of the French ATU Program.

Blood (2007) 110 (11): 1849.

https://doi.org/10.1182/blood.V110.11.1849.1849

Published: 2007

Journal Articles

Peg IFNα-2a in Polycythemia Vera (PV). Results of a Phase 2 Study by the French “PV-NORD” Group.

Jean-Jacques Kiladjian, MD, Bruno Cassinat, MD, Pascal Turlure, MD, Nathalie Cambier, MD, Sylvia Bellucci, MD,PhD, Murielle Roussel, MD, Marie-José Grange, MD, Bernard Grandchamp, MD,PhD, Jean-Didier Rain, MD,PhD, Christine Chomienne, MD,PhD, Pierre Fenaux, MD,PhD

Blood (2006) 108 (11): 670.

https://doi.org/10.1182/blood.V108.11.670.670

Published: 2006

Journal Articles

High molecular response rate of polycythemia vera patients treated with pegylated interferon α–2a

Blood (2006) 108 (6): 2037–2040.

https://doi.org/10.1182/blood-2006-03-009860

Published: 2006

NARROW

Increased Thromboinflammation Is Associated with High Thrombotic Risk in Patients with Myeloproliferative Neoplasms: A Multicentric Study of 394 Cases By the French Intergroup of Myeloproliferative Neoplasms (FIM)

Momelotinib (MMB) Long-Term Safety: Pooled Data from Three Phase 3 Randomized-Controlled Trials (RCTs)

Treatment with Temozolomide and Ibrutinib in Recurrent/Refractory Primary (PCNSL) and Secondary CNS Lymphoma (SCNSL)

Impact of DNMT3a Status on Post Induction NPM1 MRD Predictive Value on Survival in Elderly AML Patients Treated Intensively

Chemotherapy Treatment Doesn't Beneficiate to a Group of Elderly AML Patients with Absence of Complex Karyotype and Circulating Blasts

A Two-Part Study of Givinostat in Patients with Polycythemia Vera: The Maximum Tolerated Dose Selection and the Proof of Concept Final Results

Myelofibrosis in Real Life: Findings from the French Intergroup of Myeloproliferative Neoplasms (FIM) Registry

A Two-Part Study of Givinostat in Patients with Polycythemia Vera: Maximum Tolerated Dose Definition and Preliminary Efficacy Results

Procoagulant Platelet-Derived Microparticles Are Lower in Calreticulin-Than in-JAK2-Mutated Essential Thrombocythemia

Prognostic Of IgD Myeloma In The Era Of Novel Agents

High Prevalence Of Aspirin-Resistance In Myeloproliferative Neoplasms

Enumeration of Circulating Platelet-Derived Microparticles Clearly Separates PV and ET From Secondary Polycythemia or Thrombocytosis

The Phenotypic Profile of Circulating Microparticles Is Different in Polycythemia Vera and Secondary Erythrocytosis

Complete Hematological, Molecular and Histological Remissions without Cytoreductive Treatment Lasting After Pegylated-Interferon α-2a (peg-IFNα-2a) Therapy in Polycythemia Vera (PV): Long Term Results of a Phase 2 Trial

Elevated Circulating Platelet-Derived Microparticles in Ph1 Negative Chronic Myeloproliferative Disorders.

Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera

Treatment of AML with Azacytidine (AZA): Current Results of the French ATU Program.

Peg IFNα-2a in Polycythemia Vera (PV). Results of a Phase 2 Study by the French “PV-NORD” Group.

High molecular response rate of polycythemia vera patients treated with pegylated interferon α–2a

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only